Tech Company Financing Transactions
Travanti Pharma Funding Round
Travanti Pharma closed a $1.5 million investment round on 6/30/2006. Backers included Prolog Ventures.
Transaction Overview
Company Name
Announced On
6/30/2006
Transaction Type
Venture Equity
Amount
$1,500,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
2520 Pilot Knob Rd. 100
Mendota Heights, MN 55120
USA
Mendota Heights, MN 55120
USA
Phone
Website
Email Address
Overview
Travanti Pharma Inc. is a privately held corporation that designs, develops and markets innovative drug delivery platforms that improve the safety, compliance, effectiveness and ease of administration of medications, which are delivered into the body.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Walter Sembrowich
Chief Executive Officer
Robert Cohen
Chief Technical Officer
Carter Anderson
President
Chris Wright
Vice President
Daniel Ryan
VP - Bus. Development
Robert Arnold
VP - Operations
Russell Morris
Browse more venture capital transactions:
Prev: 6/30/2006: Pump Audio venture capital transaction
Next: 6/30/2006: ViaCyte venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on all VC transactions involving tech companies. All VC database entries reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs